|
|
|
Insider
Information: |
Gergel Ivan |
Relationship: |
SVP & Chief Medical Of... |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
56,553 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$70,126 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
56,553 |
|
|
Total
Value |
$70,126 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Endo Health Solutions Inc |
ENDP |
EVP, R&D and CSO |
2014-02-28 |
0 |
2009-02-26 |
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
SVP & Chief Medical Of... |
2017-11-16 |
56,553 |
2016-02-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2016-05-17 |
4 |
S |
$13.58 |
$5,867 |
D/D |
(432) |
1,512 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2016-02-17 |
4 |
S |
$11.92 |
$6,628 |
D/D |
(556) |
694 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2016-11-16 |
4 |
S |
$13.96 |
$11,838 |
D/D |
(848) |
26,479 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2014-02-27 |
4 |
D |
$79.82 |
$72,556 |
D/D |
(909) |
27,649 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,944 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2017-05-16 |
4 |
S |
$19.55 |
$28,348 |
D/D |
(1,450) |
43,572 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2017-02-16 |
4 |
S |
$13.14 |
$19,145 |
D/D |
(1,457) |
45,022 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2014-02-23 |
4 |
D |
$77.26 |
$117,203 |
D/D |
(1,517) |
15,695 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2014-02-22 |
4 |
D |
$77.26 |
$118,285 |
D/D |
(1,531) |
13,883 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2016-08-16 |
4 |
S |
$17.56 |
$29,589 |
D/D |
(1,685) |
27,327 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2017-08-16 |
4 |
S |
$19.32 |
$38,582 |
D/D |
(1,997) |
41,575 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
|
2013-02-26 |
4 |
D |
$28.09 |
$86,573 |
D/D |
(3,082) |
1,820 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2017-11-16 |
4 |
D |
$44.23 |
$222,123 |
D/D |
(5,022) |
56,553 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,658 |
35,669 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
|
2013-02-27 |
4 |
D |
$30.03 |
$215,255 |
D/D |
(7,168) |
8,556 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
|
2013-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,976 |
7,976 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2017-07-11 |
4 |
AS |
$21.04 |
$176,505 |
D/D |
(8,389) |
43,572 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Medical Officer |
|
2017-07-11 |
4 |
OE |
$11.04 |
$92,615 |
D/D |
8,389 |
51,961 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,690 |
51,399 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2014-02-26 |
4 |
D |
$78.30 |
$712,922 |
D/D |
(9,105) |
26,564 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, R&D and CSO |
|
2014-02-19 |
4 |
D |
$75.22 |
$761,753 |
D/D |
(10,127) |
12,054 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
|
2011-05-03 |
4 |
OE |
$25.02 |
$312,750 |
D/D |
12,500 |
12,500 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
|
2011-05-03 |
4 |
AS |
$39.39 |
$492,375 |
D/D |
(12,500) |
0 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Research & Development |
|
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,316 |
13,316 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|